Targeted therapies: Remembrance of things past - Discontinuation of second-generation TKI therapy for CML

Research output: Contribution to journal › Short survey

4 Citations (Scopus)

Original language	English
Pages (from-to)	201-202
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	14
Issue number	4
DOIs	https://doi.org/10.1038/nrclinonc.2017.11
Publication status	Published - 1 Apr 2017

ASJC Scopus subject areas

@article{5ca81dd85b954808adcdaa4a2496bf38,

title = "Targeted therapies: Remembrance of things past - Discontinuation of second-generation TKI therapy for CML",

author = "Timothy Hughes and Ross, {David M.}",

year = "2017",

month = "4",

day = "1",

doi = "10.1038/nrclinonc.2017.11",

language = "English",

volume = "14",

pages = "201--202",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Targeted therapies

T2 - Remembrance of things past - Discontinuation of second-generation TKI therapy for CML

AU - Hughes, Timothy

AU - Ross, David M.

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85011887038&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2017.11

DO - 10.1038/nrclinonc.2017.11

M3 - Short survey

C2 - 28169304

AN - SCOPUS:85011887038

VL - 14

SP - 201

EP - 202

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 4

ER -